taurine has been researched along with Cardiovascular Stroke in 24 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a double-blind, randomized, crossover, placebo-controlled study, we investigated the effects of adding taurine to the conventional treatment in 14 patients with congestive heart failure for a 4-week period." | 9.05 | Therapeutic effect of taurine in congestive heart failure: a double-blind crossover trial. ( Awata, N; Azuma, J; Hamaguchi, T; Harada, H; Hasegawa, H; Ishiyama, T; Ohta, H; Sawamura, A; Takihara, K; Yamagami, T, 1985) |
| "This study investigated the protective effect of subacute pre-adminsitration of either selenium (Se), taurine (Tau), or both drugs in combination against experimentally induced myocardial infarction (MI) in rats and illustrates the possible mechanisms of action." | 7.85 | A synergistic protective effect of selenium and taurine against experimentally induced myocardial infarction in rats. ( Dallak, M, 2017) |
| "We have examined the protective effect of taurine on the myocardial antioxidant defense system in isoprenaline (isoproterenol)-induced myocardial infarction in rats, an animal model of myocardial infarction in man." | 7.73 | Protective effect of taurine on myocardial antioxidant status in isoprenaline-induced myocardial infarction in rats. ( Anandan, R; Devadasan, K; Farvin, KH; Kumar, SH; Shiny, KS, 2005) |
| "The content of taurine in the hypertrophied left ventricle is increased in congestive heart failure an in spontaneously hypertensive (SH) rats." | 7.66 | Platelet taurine in patients with arterial hypertension, myocardial failure or infarction. ( Himberg, JJ; Paasonen, MK; Penttilä, O; Solatunturi, E, 1980) |
| "Atherosclerosis is the underlying mechanism of cardiovascular disease including myocardial infarctions, strokes and peripheral artery disease and remains a major cause of morbidity and mortality worldwide." | 6.50 | Taurine and atherosclerosis. ( Murakami, S, 2014) |
| "In a double-blind, randomized, crossover, placebo-controlled study, we investigated the effects of adding taurine to the conventional treatment in 14 patients with congestive heart failure for a 4-week period." | 5.05 | Therapeutic effect of taurine in congestive heart failure: a double-blind crossover trial. ( Awata, N; Azuma, J; Hamaguchi, T; Harada, H; Hasegawa, H; Ishiyama, T; Ohta, H; Sawamura, A; Takihara, K; Yamagami, T, 1985) |
| " Reduced myocardial levels of myo-inositol in the myocardium of MI animals point to altered phospholipid metabolism and membrane receptor function in heart failure." | 3.91 | Metabolomic analysis of serum and myocardium in compensated heart failure after myocardial infarction. ( Barupal, DK; Fan, S; Hammond, HK; Ichikawa, Y; McKirnan, MD; Patel, HH; Roth, DM; Zemljic-Harpf, AE; Zhang, Z, 2019) |
| "This study investigated the protective effect of subacute pre-adminsitration of either selenium (Se), taurine (Tau), or both drugs in combination against experimentally induced myocardial infarction (MI) in rats and illustrates the possible mechanisms of action." | 3.85 | A synergistic protective effect of selenium and taurine against experimentally induced myocardial infarction in rats. ( Dallak, M, 2017) |
| "We have examined the protective effect of taurine on the myocardial antioxidant defense system in isoprenaline (isoproterenol)-induced myocardial infarction in rats, an animal model of myocardial infarction in man." | 3.73 | Protective effect of taurine on myocardial antioxidant status in isoprenaline-induced myocardial infarction in rats. ( Anandan, R; Devadasan, K; Farvin, KH; Kumar, SH; Shiny, KS, 2005) |
| "The content of taurine in the hypertrophied left ventricle is increased in congestive heart failure an in spontaneously hypertensive (SH) rats." | 3.66 | Platelet taurine in patients with arterial hypertension, myocardial failure or infarction. ( Himberg, JJ; Paasonen, MK; Penttilä, O; Solatunturi, E, 1980) |
| "Atherosclerosis is the underlying mechanism of cardiovascular disease including myocardial infarctions, strokes and peripheral artery disease and remains a major cause of morbidity and mortality worldwide." | 2.50 | Taurine and atherosclerosis. ( Murakami, S, 2014) |
| "The taurine groups were given a 200 mg/kg/day dose of taurine by drinking water." | 1.91 | Interaction of exercise training with taurine attenuates infarct size and cardiac dysfunction via Akt-Foxo3a-Caspase-8 signaling pathway. ( Choobineh, S; Gaeini, A; Razzaghi, A; Soori, R, 2023) |
| " The difference in overall therapeutic effects and endogenous metabolic regulation between short- and long-term administration was still unclear." | 1.72 | LC-MS-based metabolomics reveals metabolic changes in short- and long-term administration of Compound Danshen Dripping Pills against acute myocardial infarction in rats. ( Li, B; Li, P; Wang, GJ; Wang, LL; Yang, H; Zeng, H; Zhang, L, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (33.33) | 18.7374 |
| 1990's | 3 (12.50) | 18.2507 |
| 2000's | 6 (25.00) | 29.6817 |
| 2010's | 4 (16.67) | 24.3611 |
| 2020's | 3 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, L | 1 |
| Wang, LL | 1 |
| Zeng, H | 1 |
| Li, B | 1 |
| Yang, H | 1 |
| Wang, GJ | 1 |
| Li, P | 1 |
| Razzaghi, A | 1 |
| Choobineh, S | 1 |
| Gaeini, A | 1 |
| Soori, R | 1 |
| Lee, CC | 1 |
| Chen, WT | 1 |
| Chen, SY | 1 |
| Lee, TM | 1 |
| Dallak, M | 1 |
| McKirnan, MD | 1 |
| Ichikawa, Y | 1 |
| Zhang, Z | 1 |
| Zemljic-Harpf, AE | 1 |
| Fan, S | 1 |
| Barupal, DK | 1 |
| Patel, HH | 1 |
| Hammond, HK | 1 |
| Roth, DM | 1 |
| Ardisson, LP | 1 |
| Rafacho, BP | 1 |
| Santos, PP | 1 |
| Assalin, H | 1 |
| Gonçalves, AF | 1 |
| Azevedo, PS | 1 |
| Minicucci, MF | 1 |
| Polegato, BF | 1 |
| Okoshi, K | 1 |
| Marchini, JS | 1 |
| Barbisan, LF | 1 |
| Fernandes, AA | 1 |
| Seiva, FR | 1 |
| Paiva, SA | 1 |
| Zornoff, LA | 1 |
| Murakami, S | 1 |
| Bäckström, T | 1 |
| Goiny, M | 1 |
| Lockowandt, U | 1 |
| Liska, J | 1 |
| Franco-Cereceda, A | 1 |
| Singh, RB | 1 |
| Kartikey, K | 1 |
| Charu, AS | 1 |
| Niaz, MA | 1 |
| Schaffer, S | 1 |
| Kavianipour, M | 1 |
| Wikström, G | 2 |
| Ronquist, G | 2 |
| Waldenström, A | 2 |
| Shiny, KS | 1 |
| Kumar, SH | 1 |
| Farvin, KH | 1 |
| Anandan, R | 1 |
| Devadasan, K | 1 |
| Briet, F | 1 |
| Keith, M | 1 |
| Leong-Poi, H | 1 |
| Kadakia, A | 1 |
| Aba-Alkhail, K | 1 |
| Giliberto, JP | 1 |
| Stewart, D | 1 |
| Errett, L | 1 |
| David Mazer, C | 1 |
| Yamori, Y | 1 |
| Wang, H | 1 |
| Ikeda, K | 1 |
| Kihara, M | 1 |
| Nara, Y | 1 |
| Horie, R | 1 |
| Paasonen, MK | 2 |
| Penttilä, O | 1 |
| Himberg, JJ | 1 |
| Solatunturi, E | 2 |
| Cooper, MW | 3 |
| Lombardini, JB | 3 |
| Allo, SN | 1 |
| Bagby, L | 1 |
| Schaffer, SW | 1 |
| Ding, W | 1 |
| Li, D | 1 |
| Zhang, J | 1 |
| Zemgulis, V | 1 |
| Bjerner, T | 1 |
| Henze, A | 1 |
| Thelin, S | 1 |
| Bhatnagar, SK | 1 |
| Welty, JD | 1 |
| al Yusuf, AR | 1 |
| Azuma, J | 1 |
| Sawamura, A | 1 |
| Awata, N | 1 |
| Ohta, H | 1 |
| Hamaguchi, T | 1 |
| Harada, H | 1 |
| Takihara, K | 1 |
| Hasegawa, H | 1 |
| Yamagami, T | 1 |
| Ishiyama, T | 1 |
| Nieminen, ML | 1 |
| Gagliarducci, U | 1 |
1 review available for taurine and Cardiovascular Stroke
| Article | Year |
|---|---|
Taurine and atherosclerosis.
Topics: Animals; Atherosclerosis; Disease Models, Animal; Humans; Hyperlipidemias; Myocardial Infarction; Ta | 2014 |
3 trials available for taurine and Cardiovascular Stroke
| Article | Year |
|---|---|
Effect of taurine and coenzyme Q10 in patients with acute myocardial infarction.
Topics: Coenzymes; Female; Humans; Male; Myocardial Infarction; Taurine; Ubiquinone | 2003 |
Therapeutic effect of taurine in congestive heart failure: a double-blind crossover trial.
Topics: Administration, Oral; Aged; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Drug Th | 1985 |
[Treatment of acute ischemic heart disease using taurine. Clinical study of 30 cases].
Topics: Acute Disease; Adult; Clinical Trials as Topic; Drug Evaluation; Electrocardiography; Hemodynamics; | 1974 |
20 other studies available for taurine and Cardiovascular Stroke
| Article | Year |
|---|---|
LC-MS-based metabolomics reveals metabolic changes in short- and long-term administration of Compound Danshen Dripping Pills against acute myocardial infarction in rats.
Topics: Animals; Camphanes; Chromatography, Liquid; Drugs, Chinese Herbal; Metabolomics; Myocardial Infarcti | 2022 |
Interaction of exercise training with taurine attenuates infarct size and cardiac dysfunction via Akt-Foxo3a-Caspase-8 signaling pathway.
Topics: Animals; Caspase 8; Male; Myocardial Infarction; Myocardium; Physical Conditioning, Animal; Proto-On | 2023 |
Taurine Alleviates Sympathetic Innervation by Inhibiting NLRP3 Inflammasome in Postinfarcted Rats.
Topics: Animals; Anti-Inflammatory Agents; Disease Models, Animal; Inflammasomes; Inflammation; Interleukin- | 2021 |
A synergistic protective effect of selenium and taurine against experimentally induced myocardial infarction in rats.
Topics: Animals; bcl-2-Associated X Protein; Biomarkers; Disease Models, Animal; Drug Synergism; Electrocard | 2017 |
Metabolomic analysis of serum and myocardium in compensated heart failure after myocardial infarction.
Topics: Animals; Echocardiography; Female; Heart Failure; Heart Ventricles; Inosine; Inositol; Male; Metabol | 2019 |
Taurine attenuates cardiac remodeling after myocardial infarction.
Topics: Animals; Biomarkers; Diastole; Echocardiography; Male; Myocardial Infarction; Rats; Rats, Wistar; Ta | 2013 |
Cardiac outflow of amino acids and purines during myocardial ischemia and reperfusion.
Topics: Amino Acids; Animals; Aspartic Acid; Female; Guanosine; Hemodynamics; Hypoxanthine; Inosine; Male; M | 2003 |
Validity of elevated interstitial levels of taurine as a predictor of myocardial ischemic injury.
Topics: Animals; Area Under Curve; Ischemia; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfus | 2004 |
Protective effect of taurine on myocardial antioxidant status in isoprenaline-induced myocardial infarction in rats.
Topics: Animals; Antioxidants; Glutathione; Glutathione Peroxidase; Glutathione Transferase; Heart; Injectio | 2005 |
Triple nutrient supplementation improves survival, infarct size and cardiac function following myocardial infarction in rats.
Topics: Acyl-CoA Dehydrogenase; Animals; Cardiac Output; Carnitine; Carnitine O-Palmitoyltransferase; Dietar | 2008 |
Role of sulfur amino acids in the prevention and regression of cardiovascular diseases.
Topics: Amino Acids, Sulfur; Animals; Arteriosclerosis; Blood Pressure; Cardiovascular Diseases; Cerebrovasc | 1983 |
Platelet taurine in patients with arterial hypertension, myocardial failure or infarction.
Topics: Aged; Blood Platelets; Female; Heart Failure; Humans; Hypertension; Male; Middle Aged; Myocardial In | 1980 |
Elevated blood taurine levels after myocardial infarction of cardiovascular surgery: is there any significance?
Topics: Animals; Cardiac Surgical Procedures; Coronary Artery Bypass; Creatine Kinase; Dogs; Heart; Humans; | 1981 |
Amino acid concentrations in blood of patients with an acute myocardial infarction.
Topics: Amino Acids; Humans; Kinetics; Myocardial Infarction; Taurine | 1982 |
Elevated blood taurine levels in acute and evolving myocardial infarction.
Topics: Acute Disease; Clinical Laboratory Techniques; Creatine Kinase; Diagnosis, Differential; Humans; Kin | 1981 |
Taurine depletion, a novel mechanism for cardioprotection from regional ischemia.
Topics: Animals; beta-Alanine; In Vitro Techniques; Male; Myocardial Infarction; Myocardial Ischemia; Myocar | 1997 |
[Influences of taurine on thrombolysis].
Topics: Aged; Animals; Endothelins; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infar | 1996 |
Energy-related metabolites during and after induced myocardial infarction with special emphasis on the reperfusion injury after extracorporeal circulation.
Topics: Adenosine; Animals; Chromatography, High Pressure Liquid; Dialysis Solutions; Disease Models, Animal | 2001 |
Significance of blood taurine levels in patients with first time acute ischaemic cardiac pain.
Topics: Adult; Angina Pectoris; Angina, Unstable; Biomarkers; Creatine Kinase; Humans; Male; Middle Aged; My | 1990 |
Blood platelets: accumulation and release of taurine.
Topics: Animals; Biological Transport, Active; Blood Platelets; Heart Failure; Humans; Hypertension; In Vitr | 1985 |